Primary Site >> Stomach Cancer
Gene >> PTGES
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. PMID: 14520691 |
Ref: Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. PMID: 15014433 Ref: Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis. PMID: 15372235 |
Ref: Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. PMID: 16230370 |
Ref: Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. PMID: 16760271 Ref: Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. PMID: 17030179 |
Ref: Clinical significance of prostaglandin E synthase expression in gastric cancer tissue. PMID: 17868774 |
Ref: Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice. PMID: 19018769 |
Ref: Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. PMID: 20015407 |
Ref: Inhibition of beta-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo. PMID: 25331984 |